ArticleAnnals of biomedical engineering2026
Hemodynamic Effects of Aortic Stenosis on Coronary Flow Dynamics.
Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeAortic stenosis (AS) commonly coexists with coronary artery disease (CAD), yet the direct hemodynamic link between valve function, coronary flow waveforms, and spatial wall shear stress (WSS) remains poorly defined. This study isolates and quantifies how AS-induced flow alterations generate atheroprone coronary environments.
methodsAn in vitro mock circulation loop modeled severe AS (effective orifice area 0.7 cm
resultsCompared to TAVR, severe AS produced higher systolic transvalvular pressure gradients (45-70 mmHg vs. 10-25 mmHg) and lower aortic-sinus gradients, particularly at elevated heart rates (HR). Diastolic CBF was elevated at normal HR but declined with increasing HR, resulting in increased pulsatility and reduced coronary flow reserve. CFD revealed larger regions of atheroprone WSS in AS, predominantly on convex arterial curvatures, while elevated WSS localized to concave regions. TAVR reduced adverse WSS exposure by 30-50%.
conclusionAS induces hemodynamic disturbances associated with atheroprone environments through altered coronary flow and adverse WSS patterns. TAVR mitigates these effects, highlighting opportunities for valve design optimization to improve the local coronary fluid-dynamic environment.
Indexed as
Identifiers
42554771What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.